Abstract:The human large intestinal microbiota thrives on dietary carbohydrates that are converted to a range of fermentation products. Short-chain fatty acids (acetate, propionate and butyrate) are the dominant fermentation acids that accumulate to high concentrations in the colon and they have health-promoting effects on the host. Although many gut microbes can also produce lactate, it usually does not accumulate in the healthy gut lumen. This appears largely to be due to the presence of a relatively small number of … Show more
“…As illustrated in Figure 1 , butyrate is produced by a distinct group of gut bacteria via either the CoA-transferase or butyrate kinase pathways [ 23 , 24 , 25 ]. Butyrate can only be produced by a distinct group of gut microbes, including Faecalibacterium prausnitzii and Eubacterium rectale [ 26 ]. A number of studies have identified that butyrate-producing bacteria are depleted in the gut microbiota of patients with inflammatory bowel diseases (including Crohn’s disease and ulcerative colitis) and colorectal cancer compared to healthy people [ 21 , 27 ].…”
Section: Postbiotics and Human Gut Healthmentioning
confidence: 99%
“…Acetate is the most abundant SCFA in the gut reaching a molar ratio three times larger than butyrate and propionate [ 16 , 26 , 33 ]. Acetate is produced through the fermentation of dietary fibres by gut bacteria, including Ruminococcus spp., Prevotella spp., Bifidobacterium spp.…”
Section: Postbiotics and Human Gut Healthmentioning
confidence: 99%
“…The postbiotic preparations of lactic acid bacteria are rich in lactate and acetate that can have a positive down-stream effect on butyrate and propionate concentrations in the gut when converted through cross-feeding by endogenous butyrate and propionate-producers. As illustrated in Figure 1 , lactate can be converted to butyrate via the CoA-transferase pathway by microbes, such as Anaerobutyricum and Anaerostipes species [ 23 , 24 , 26 ]. Lactate can also be converted to propionate via two pathways, namely the acrylate pathway by microbes, including Coprococcus catus and Megasphaera elsdenii , or the succinate pathway by microbes, including the Veillonella species [ 23 , 24 , 26 ].…”
Section: Postbiotics and Human Gut Healthmentioning
confidence: 99%
“…As illustrated in Figure 1 , lactate can be converted to butyrate via the CoA-transferase pathway by microbes, such as Anaerobutyricum and Anaerostipes species [ 23 , 24 , 26 ]. Lactate can also be converted to propionate via two pathways, namely the acrylate pathway by microbes, including Coprococcus catus and Megasphaera elsdenii , or the succinate pathway by microbes, including the Veillonella species [ 23 , 24 , 26 ]. However, where butyrate and propionate producers are not present in the gut, as is the case in some disease states, the increasing concentrations of lactate and acetate will not result in an increase in butyrate or propionate [ 21 , 27 ].…”
Section: Postbiotics and Human Gut Healthmentioning
Postbiotics are a new category of biotics that have the potential to confer health benefits but, unlike probiotics, do not require living cells to induce health effects and thus are not subject to the food safety requirements that apply to live microorganisms. Postbiotics are defined as a “preparation of inanimate microorganisms and/or their components that confers a health benefit on the host”. Postbiotic components include short-chain fatty acids, exopolysaccharides, vitamins, teichoic acids, bacteriocins, enzymes and peptides in a non-purified inactivated cell preparation. While research into postbiotics is in its infancy, there is increasing evidence that postbiotics have the potential to modulate human health. Specifically, a number of postbiotics have been shown to improve gut health by strengthening the gut barrier, reducing inflammation and promoting antimicrobial activity against gut pathogens. Additionally, research is being conducted into the potential application of postbiotics to other areas of the body, including the skin, vagina and oral cavity. The purpose of this review is to set out the current research on postbiotics, demonstrate how postbiotics are currently used in commercial products and identify a number of knowledge gaps where further research is needed to identify the potential for future applications of postbiotics.
“…As illustrated in Figure 1 , butyrate is produced by a distinct group of gut bacteria via either the CoA-transferase or butyrate kinase pathways [ 23 , 24 , 25 ]. Butyrate can only be produced by a distinct group of gut microbes, including Faecalibacterium prausnitzii and Eubacterium rectale [ 26 ]. A number of studies have identified that butyrate-producing bacteria are depleted in the gut microbiota of patients with inflammatory bowel diseases (including Crohn’s disease and ulcerative colitis) and colorectal cancer compared to healthy people [ 21 , 27 ].…”
Section: Postbiotics and Human Gut Healthmentioning
confidence: 99%
“…Acetate is the most abundant SCFA in the gut reaching a molar ratio three times larger than butyrate and propionate [ 16 , 26 , 33 ]. Acetate is produced through the fermentation of dietary fibres by gut bacteria, including Ruminococcus spp., Prevotella spp., Bifidobacterium spp.…”
Section: Postbiotics and Human Gut Healthmentioning
confidence: 99%
“…The postbiotic preparations of lactic acid bacteria are rich in lactate and acetate that can have a positive down-stream effect on butyrate and propionate concentrations in the gut when converted through cross-feeding by endogenous butyrate and propionate-producers. As illustrated in Figure 1 , lactate can be converted to butyrate via the CoA-transferase pathway by microbes, such as Anaerobutyricum and Anaerostipes species [ 23 , 24 , 26 ]. Lactate can also be converted to propionate via two pathways, namely the acrylate pathway by microbes, including Coprococcus catus and Megasphaera elsdenii , or the succinate pathway by microbes, including the Veillonella species [ 23 , 24 , 26 ].…”
Section: Postbiotics and Human Gut Healthmentioning
confidence: 99%
“…As illustrated in Figure 1 , lactate can be converted to butyrate via the CoA-transferase pathway by microbes, such as Anaerobutyricum and Anaerostipes species [ 23 , 24 , 26 ]. Lactate can also be converted to propionate via two pathways, namely the acrylate pathway by microbes, including Coprococcus catus and Megasphaera elsdenii , or the succinate pathway by microbes, including the Veillonella species [ 23 , 24 , 26 ]. However, where butyrate and propionate producers are not present in the gut, as is the case in some disease states, the increasing concentrations of lactate and acetate will not result in an increase in butyrate or propionate [ 21 , 27 ].…”
Section: Postbiotics and Human Gut Healthmentioning
Postbiotics are a new category of biotics that have the potential to confer health benefits but, unlike probiotics, do not require living cells to induce health effects and thus are not subject to the food safety requirements that apply to live microorganisms. Postbiotics are defined as a “preparation of inanimate microorganisms and/or their components that confers a health benefit on the host”. Postbiotic components include short-chain fatty acids, exopolysaccharides, vitamins, teichoic acids, bacteriocins, enzymes and peptides in a non-purified inactivated cell preparation. While research into postbiotics is in its infancy, there is increasing evidence that postbiotics have the potential to modulate human health. Specifically, a number of postbiotics have been shown to improve gut health by strengthening the gut barrier, reducing inflammation and promoting antimicrobial activity against gut pathogens. Additionally, research is being conducted into the potential application of postbiotics to other areas of the body, including the skin, vagina and oral cavity. The purpose of this review is to set out the current research on postbiotics, demonstrate how postbiotics are currently used in commercial products and identify a number of knowledge gaps where further research is needed to identify the potential for future applications of postbiotics.
“…Colonic CO2 is a fermentative subproduct of the bicarbonate/acid reaction performed by commensals such as Bifidobacteria and butyrate-producing Clostridial clusters(Heresbach et al, 1995;Rivière et al, 2016). Short-chain fatty acids (acetate, propionate and butyrate) are the dominant fermentation acids that accumulate to high concentrations in the colon(Louis et al, 2022). The extreme acid load associated with high colonic p CO2 is partially counteracted by the proximal colon epithelium's apical membrane, that provides a significant resistance towards CO2 diffusion and confers cellular protection(Endeward and Gros, 2005).The intestinal CO2 enters red blood cells and is converted to carbonic acid, which dissociates to hydrogen ion and bicarbonate.…”
Intestinal gases are usually discarded as physiologically inert, useless sub-products of colonic fermentation that must be expelled to prevent discomfort and meteorism. Starting from the observation that many living beings use exogenous and/or endogenous gases to attain evolutionary benefits, we question whether intestinal gases in healthy humans could have underestimated physiological effects, either intestinal or extra-intestinal. We examine gaseous volume, composition, source and local distribution in proximal as well as distal gut, providing extensive data that may serve as reference for future studies. We analyze each one of the most abundant intestinal gases and describe their diffusive patterns, active trans-barrier transport dynamics, chemical properties, intra-/extra-intestinal metabolic effects mediated by intracellular, extracellular, paracrine and distant actions. Discussing the physical properties of the whole intestinal gaseous mixture, we illustrate how changes in volume/pressure can be generated by two different mechanisms, namely, physical muscular gut contraction and biological colonic fermentation, with quite different metabolic outcomes. The experimental gas laws suggest that the gaseous exchanges between lumen and bloodstream are impaired by muscular contraction and improved by muscular relaxation. In turn, the surface-area-to-volume ratio suggests that the gaseous exchanges are impaired by microorganismal overproduction and improved by microorganismal reduction. Further, theoretical stochastic approaches from probability theory indicate that the non-turbulent, random paths of gas molecules inside colonic haustra do not homogenously spread over the whole mucosal surface. This means that the intestinal area available for lumen/blood metabolic exchanges is much less than expected not just in disease states, but also in healthy individuals.
ScopeGastro‐AD (GAD) is a soy flour derived product that undergoes an industrial fermentation with Lactobacillus delbrueckii R0187 and has demonstrated clinical effects in gastroesophageal reflux and peptic ulcer symptom resolution. The aim of this study is to describe and link GAD's metabolomic profile to plausible mechanisms that manifest and explain the documented clinical outcomes.Methods and results1H NMR spectroscopy with multivariate statistical analysis is used to characterize the prefermented soy flour and GAD products. The acquired spectra are screened using various resources and the molecular assignments are confirmed using total correlation spectroscopy (TOCSY). Peaks corresponding to different metabolites are integrated and compared between the two products for relative changes. HPLC and GC are used to quantify some specific molecules. NMR analyses demonstrate significant changes in the composition of various assigned bioactive moieties. HPLC and GC analysis demonstrate deglycation of isoflavones after fermentation, resulting in estrogenically active secondary metabolites that have been previously shown to help to reduce inflammation.ConclusionThe identification of bioactive molecules, such as genistein and SCFAs, capable of modulating anti‐inflammatory signaling cascades in the stomach's gastric and neuroendocrine tissues can explain the reported biological effects in GAD and is supported by in vivo data.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.